The Effect of Naftopidil for the Double-J Stent Discomfort

Disorder of Urinary Stent Clinical Trial

Official title: The Effect of Naftopidil for the Double-J Stent Discomfort: Multicenter, Randomized, Double-blind, Placebo Controlled Study

Status Completed

Clinical Trial Summary

This study is To confirm the efficacy of Naftopidil for reducing discomfort of ureteral stent after urinary stone surgery.

Clinical Trial Description

1. Enrollment

1. patients underwent Double-J ureteral stent indwelling after urological surgery during less than 15 days

2. patients aged more than 20 years

2. Randomization

1. naftopidil 75 mg qd or placebo until Double-J stent removal

2. Standard treatment with pain-killers on demand were also applied.(aceclofenac)

3. Follow-up to the day of Double-J stent removal (Evaluation should be done at stent removal) ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Disorder of Urinary Stent

• NCT number: NCT01959074
• Study type: Interventional
• Source: Seoul National University Hospital
• Status: Completed
• Phase: Phase 3
• Start date: May 2014
• Completion date: June 2015